Business
Definitive Healthcare Announces Closing of Public Offering
FRAMINGHAM, Mass.--(BUSINESS WIRE)-- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial
About this update from Definitive Healthcare Corp.
[{"type":"text","content":" FRAMINGHAM, Mass.--(BUSINESS WIRE)--\nDefinitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced the closing of its previously announced initial public offering of 17,888,888 shares of its Class A common stock, which includes the full exercise by the underwriters of their option to purchase up to an additional 2,333,333 shares of its Class A common stock, at a public offering price of $27.00 per share. Aggregate gross proceeds to Definitive Healthcare were approximately $483 million, before underwriting discounts, commissions, and estimated offering expenses. Definitive Healthcare’s Class A common stock began trading on the Nasdaq Global Select Market under the ticker symbol “DH” on September 15, 2021.\n\nGoldman Sachs & Co. LLC and J.P. Morgan acted as lead joint book-running managers and representatives of the underwriters for the proposed offering. Morgan Stanley and Barclays acted as joint book-running managers and are also representatives of the underwriters for the proposed offering. Credit Suisse and Deutsche Bank Securities acted as book-runners for the proposed offering. Canaccord Genuity, Raymond James, Stifel, Drexel Hamilton and Loop Capital Markets acted as co-managers.\n\nThe offering was made only by means of a prospectus. A copy of the final prospectus relating to the proposed offering may be obtained from the SEC at www.sec.gov or from: Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at [email protected]; J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, by telephone at (866) 803-9204 or by email at [email protected]; Morgan Stanley & Co. LLC, Attn: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, by telephone at (866) 718-1649 or by email at [email protected]; or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by telephone at (888) 603-5847 or by at email at [email protected].\n\nA registration statement relating to these securities was declared effective by the Securities and Exchange Commission on September 14, 2021. This press release shall not ...